These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5936693)

  • 1. Myocardial infarction with shock. Hemodynamic studies and results of therapy.
    Gunnar RM; Cruz A; Boswell J; Co BS; Pietras RJ; Tobin JR
    Circulation; 1966 May; 33(5):753-62. PubMed ID: 5936693
    [No Abstract]   [Full Text] [Related]  

  • 2. The physiologic basis for treatment of shock associated with myocardial infarction.
    Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR
    Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular contraction and the therapy of cardiogenic shock.
    Ross J
    Circulation; 1967 Apr; 35(4):611-3. PubMed ID: 6024005
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction.
    Ratshin RA; Rackley CE; Russell RO
    Circulation; 1972 Jan; 45(1):127-39. PubMed ID: 5007030
    [No Abstract]   [Full Text] [Related]  

  • 5. Shock after acute myocardial infarction.
    Cronin RF
    Am Heart J; 1966 Aug; 72(2):282-3. PubMed ID: 5915562
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
    Diamond G; Forrester J; Danzig R; Parmley WW; Swan HJ
    Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran.
    Cohn JN; Luria MH
    Arch Intern Med; 1965 Oct; 116(4):562-6. PubMed ID: 4284276
    [No Abstract]   [Full Text] [Related]  

  • 8. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of norepinephrine and isoproterenol in experimental coronary shock. Observations on the effects of dextran infusion.
    Fearon RE
    Am Heart J; 1968 May; 75(5):634-48. PubMed ID: 5645989
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction.
    Binder MJ
    Am J Cardiol; 1965 Dec; 16(6):834-40. PubMed ID: 5846008
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN.
    COHN JN; LURIA MH
    J Clin Invest; 1965 Sep; 44(9):1494-504. PubMed ID: 14332162
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
    Mueller H; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
    J Clin Invest; 1970 Oct; 49(10):1885-902. PubMed ID: 5460498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of shock in myocardial infarct with dextran and noradrenaline].
    Sedziwy L
    Wiad Lek; 1977 Jan; 30(1):31-5. PubMed ID: 835259
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute circulatory failure secondary to myocardial infarction.
    McCann WD; O'Donovan TP
    Postgrad Med; 1971 May; 49(5):74-9. PubMed ID: 4325238
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic alterations and results of treatment in patients with gram-negative septic shock.
    Motsay GJ; Dietzman RH; Ersek RA; Lillehei RC
    Surgery; 1970 Apr; 67(4):577-83. PubMed ID: 4908041
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
    Misra SN; Kezdi P
    Am J Cardiol; 1973 Jun; 31(6):724-35. PubMed ID: 4145230
    [No Abstract]   [Full Text] [Related]  

  • 17. Variability in response to norepinephrine in acute myocardial infarction.
    Abrams E; Forrester JS; Chatterjee K; Danzig R; Swan HJ
    Am J Cardiol; 1973 Dec; 32(7):919-23. PubMed ID: 4757231
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic measurements in a coronary care unit.
    Gunnar RM; Loeb HS; Pietras RJ; Tobin JR
    Prog Cardiovasc Dis; 1968 Jul; 11(1):29-44. PubMed ID: 4871947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low molecular dextran in the treatment of shock not related to the primary loss of body fluids].
    Dyduszyński A
    Pol Tyg Lek; 1969 Jan; 24(4):121-4. PubMed ID: 4887633
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS
    Am J Cardiol; 1974 Apr; 33(4):521-8. PubMed ID: 4818050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.